EGFR and non-small cell lung carcinoma: The epidermal growth factor receptor (EGFR), which facilitates cell growth and proliferation, is a primary oncogenic driver of NSCLC (Herbst et al., 2018; Gong et al., 2020; Leiter et al., 2023; Liu et al., 2023).